Equine Corneal Wound Healing Using Mesenchymal Stem Cell Secretome: Case Report.

Alejandro Casado-Santos, Elsa González-Cubero, Maria Luisa González-Fernández, Yaiza González-Rodríguez, Mª Belén García-Rodríguez, Vega Villar-Suárez
Author Information
  1. Alejandro Casado-Santos: Department of Surgery, Medicine and Veterinary Anatomy, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon, 24071 Léon, Spain. ORCID
  2. Elsa González-Cubero: Department of Neurosurgery, Stanford School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
  3. Maria Luisa González-Fernández: Department of Surgery, Medicine and Veterinary Anatomy, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon, 24071 Léon, Spain. ORCID
  4. Yaiza González-Rodríguez: Department of Surgery, Medicine and Veterinary Anatomy, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon, 24071 Léon, Spain.
  5. Mª Belén García-Rodríguez: Department of Surgery, Medicine and Veterinary Anatomy, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon, 24071 Léon, Spain.
  6. Vega Villar-Suárez: Department of Surgery, Medicine and Veterinary Anatomy, Faculty of Veterinary Sciences, Campus de Vegazana, University of Léon, 24071 Léon, Spain. ORCID

Abstract

Corneal ulcers are a common and potentially vision-threatening condition in horses that can be challenging to treat with conventional therapies alone. This case report describes the successful treatment of a non-healing corneal ulcer in a 28-year-old Hispano-Bretón mare using the secretome derived from adipose tissue-derived mesenchymal stem cells (ASCs). Despite initial treatment with antibiotics, anti-inflammatory drugs, and surgical debridement, the corneal ulcer failed to heal properly, exhibiting persistent epithelial defects and stromal complications. As an alternative regenerative approach, the ASC secretome, a rich source of trophic factors, cytokines, and extracellular vesicles, was topically administered to the affected eye. Remarkably, within one week of secretome treatment, the clinical signs of blepharospasm and epiphora resolved, and the corneal ulcer exhibited complete re-epithelialization, regained transparency, and reduced neovascularization. No recurrence was observed during the 1.5-year follow-up period. This case highlights the potential therapeutic benefits of the ASC secretome in promoting corneal wound healing and suggests its promise as a novel cell-free therapy for treating refractory corneal ulcers in horses.

Keywords

References

  1. Vet Ophthalmol. 2014 Jul;17 Suppl 1:46-52 [PMID: 25126664]
  2. Biosci Trends. 2019;13(4):299-307 [PMID: 31527327]
  3. Cells. 2022 Dec 02;11(23): [PMID: 36497151]
  4. Stem Cell Res Ther. 2018 Aug 9;9(1):207 [PMID: 30092820]
  5. Biochim Biophys Acta. 2013 Nov;1834(11):2380-4 [PMID: 23376432]
  6. Compend Contin Educ Vet. 2013 Jan;35(1):E4 [PMID: 23532729]
  7. Front Vet Sci. 2022 Mar 17;9:843744 [PMID: 35372560]
  8. Tierarztl Prax Ausg G Grosstiere Nutztiere. 2020 Apr;48(2):92-97 [PMID: 32325498]
  9. J Equine Vet Sci. 2023 Feb;121:104189 [PMID: 36464033]
  10. Bone Marrow Transplant. 2019 Aug;54(Suppl 2):789-792 [PMID: 31431712]
  11. Stem Cell Rev Rep. 2020 Apr;16(2):301-322 [PMID: 31797146]
  12. Front Med (Lausanne). 2022 Sep 23;9:885780 [PMID: 36213677]
  13. J Tradit Complement Med. 2019 May 03;10(5):440-445 [PMID: 32953559]
  14. Vet Ophthalmol. 2003 Dec;6(4):291-7 [PMID: 14641825]
  15. Curr Issues Mol Biol. 2024 Apr 09;46(4):3251-3277 [PMID: 38666934]
  16. Stem Cells Transl Med. 2019 May;8(5):478-489 [PMID: 30644653]
  17. Vet Sci. 2022 Nov 21;9(11): [PMID: 36423096]
  18. Stem Cells Int. 2018 Jan 30;2018:8179013 [PMID: 29535781]
  19. Cells. 2019 May 16;8(5): [PMID: 31100966]
  20. Stem Cell Res Ther. 2018 Mar 9;9(1):63 [PMID: 29523213]
  21. Cells. 2022 Aug 16;11(16): [PMID: 36010626]
  22. Biomed Res Int. 2014;2014:965849 [PMID: 25530971]
  23. Prog Retin Eye Res. 2022 Nov;91:101090 [PMID: 35649962]
  24. Int J Mol Sci. 2017 Aug 25;18(9): [PMID: 28841158]
  25. J Am Vet Med Assoc. 1986 Feb 1;188(3):295-7 [PMID: 3949604]
  26. Pharmaceutics. 2023 May 13;15(5): [PMID: 37242728]

Word Cloud

Created with Highcharts 10.0.0cornealsecretomeulcerhorsestreatmentCornealulcerscasenon-healingadiposemesenchymalstemcellsASCcommonpotentiallyvision-threateningconditioncanchallengingtreatconventionaltherapiesalonereportdescribessuccessful28-year-oldHispano-Bretónmareusingderivedtissue-derivedASCsDespiteinitialantibioticsanti-inflammatorydrugssurgicaldebridementfailedhealproperlyexhibitingpersistentepithelialdefectsstromalcomplicationsalternativeregenerativeapproachrichsourcetrophicfactorscytokinesextracellularvesiclestopicallyadministeredaffectedeyeRemarkablywithinoneweekclinicalsignsblepharospasmepiphoraresolvedexhibitedcompletere-epithelializationregainedtransparencyreducedneovascularizationrecurrenceobserved15-yearfollow-upperiodhighlightspotentialtherapeuticbenefitspromotingwoundhealingsuggestspromisenovelcell-freetherapytreatingrefractoryEquineWoundHealingUsingMesenchymalStemCellSecretome:CaseReporttissue

Similar Articles

Cited By